2019
DOI: 10.1126/sciadv.aaw9180
|View full text |Cite
|
Sign up to set email alerts
|

High-throughput mapping of CoA metabolites by SAMDI-MS to optimize the cell-free biosynthesis of HMG-CoA

Abstract: Metabolic engineering uses enzymes to produce small molecules with industrial, pharmaceutical, and energy applications. However, efforts to optimize enzymatic pathways for commercial production are limited by the throughput of assays for quantifying metabolic intermediates and end products. We developed a multiplexed method for profiling CoA-dependent pathways that uses a cysteine-terminated peptide to covalently capture CoA-bound metabolites. Captured metabolites are then rapidly separated from the complex mi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 43 publications
(38 citation statements)
references
References 49 publications
0
36
0
Order By: Relevance
“…This study reports the first label-free and high-throughput assay to measure coronavirus 3CLpro activity and opens avenues for improved drug discovery efforts to find small molecule inhibitors to treat COVID-19. The SAMDI-MS technology has been reported to characterize dozens of biochemical activities including post-translational modifying enzymes ( Gurard-Levin et al, 2011 ; Swalm et al, 2014 ; Patel et al, 2015 ; Wigle et al, 2015 ; Szymczak et al, 2018 ; O'Kane et al, 2019 ), RNA-modifying proteins ( Buker et al, 2020 ), and proteases ( Min et al, 2004 ) and can be applied to virtually any enzymatic activity. While the FRET-based assay format is convenient and can easily be adopted by standard biochemistry labs, this study demonstrates that SAMDI-MS offers distinct advantages over label-dependent FRET that were critical in developing the SARS-CoV-2 3CLpro assay ( Fig.…”
Section: Discussionmentioning
confidence: 99%
“…This study reports the first label-free and high-throughput assay to measure coronavirus 3CLpro activity and opens avenues for improved drug discovery efforts to find small molecule inhibitors to treat COVID-19. The SAMDI-MS technology has been reported to characterize dozens of biochemical activities including post-translational modifying enzymes ( Gurard-Levin et al, 2011 ; Swalm et al, 2014 ; Patel et al, 2015 ; Wigle et al, 2015 ; Szymczak et al, 2018 ; O'Kane et al, 2019 ), RNA-modifying proteins ( Buker et al, 2020 ), and proteases ( Min et al, 2004 ) and can be applied to virtually any enzymatic activity. While the FRET-based assay format is convenient and can easily be adopted by standard biochemistry labs, this study demonstrates that SAMDI-MS offers distinct advantages over label-dependent FRET that were critical in developing the SARS-CoV-2 3CLpro assay ( Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, cell‐free systems have emerged as an attractive and powerful platform for biomanufacturing (Bundy et al, 2018; Carlson, Gan, Hodgman, & Jewett, 2012; Dudley, Karim, & Jewett, 2015; Li, Zhang, & Liu, 2018; Liu, Zhang, Chen, & Li, 2019; Silverman, Karim, & Jewett, 2020; Swartz, 2018). In this context, cell‐free protein synthesis (CFPS) plays a core role in the production of various proteins in vitro (Jaroentomeechai et al, 2018; Kwon et al, 2013; Li et al, 2016; Lu, Welsh, & Swartz, 2014; Martin et al, 2018; McNerney et al, 2019; O'Kane, Dudley, McMillan, Jewett, & Mrksich, 2019; Wilding et al, 2019). Because of the absence of cell walls, cell‐free systems bypass mass transfer limitations and are more tolerant of toxic substrates, intermediates, and products than living microbial cells.…”
Section: Figurementioning
confidence: 99%
“…Currently, existing TOF mass spectrometers experimentally achieve a mass resolution of up to 300,000 in the full mass range in biochemical applications, or up to 600,000 in a limited mass range in nuclear physics research . Compared with this, the aberration limit achieved in the proposed analyzer (excluding the turnaround time) with very low ion emission (1% energy dispersion) is estimated by us as 30,000.…”
Section: Results and Discussion – Resolution Estimations Of Multi‐casmentioning
confidence: 98%